HUP0202764A2 - Aktív és inaktív fázist tartalmazó, úszó gyógyszerkészítmény - Google Patents
Aktív és inaktív fázist tartalmazó, úszó gyógyszerkészítményInfo
- Publication number
- HUP0202764A2 HUP0202764A2 HU0202764A HUP0202764A HUP0202764A2 HU P0202764 A2 HUP0202764 A2 HU P0202764A2 HU 0202764 A HU0202764 A HU 0202764A HU P0202764 A HUP0202764 A HU P0202764A HU P0202764 A2 HUP0202764 A2 HU P0202764A2
- Authority
- HU
- Hungary
- Prior art keywords
- active phase
- phase
- active
- active ingredient
- tablet
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000012071 phase Substances 0.000 abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 3
- 239000012073 inactive phase Substances 0.000 abstract 3
- 239000000463 material Substances 0.000 abstract 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 230000002378 acidificating effect Effects 0.000 abstract 2
- 229910052783 alkali metal Inorganic materials 0.000 abstract 2
- -1 alkaline earth metal carbonate Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 2
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 2
- 239000011707 mineral Substances 0.000 abstract 2
- 235000010755 mineral Nutrition 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 abstract 1
- 229910001634 calcium fluoride Inorganic materials 0.000 abstract 1
- 229910052918 calcium silicate Inorganic materials 0.000 abstract 1
- 239000000378 calcium silicate Substances 0.000 abstract 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 abstract 1
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract 1
- 239000001569 carbon dioxide Substances 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 abstract 1
- 235000015497 potassium bicarbonate Nutrition 0.000 abstract 1
- 239000011736 potassium bicarbonate Substances 0.000 abstract 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 150000004760 silicates Chemical class 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Saccharide Compounds (AREA)
Abstract
A találmány tárgya úszó gyógyszerkészítmény, amely tartalmaz legalábbegy első, aktív fázist, és egy második, inaktív fázist. A találmánytaz jellemzi, hogy az aktív fázis legalább egy hatóanyagot tartalmazegy vagy több kötőanyaggal, és az inaktív fázis legalább egygázfejlesztő rendszert, valamint legalább egy hidrofil polimert vagyporózus ásványi vegyületet tartalmaz. Az aktív fázisban a hatóanyagmennyisége legalább 80, előnyösen legalább 85, még előnyösebbenlegalább 90 tömeg%. Az inaktív fázis hidrofil polimerje poliszacharidanyagok, ezekkel rokon anyagok és fehérje anyagok közül vankiválasztva, míg a porózus ásványi vegyület a szilikátok ésszármazékaik közül van kiválasztva, például kalcium-szilikát vagykalcium-fluorid- alapú mátrix. A szén-dioxidot fejlesztő rendszeralkáli- vagy alkáliföldfém-karbonátot, például kalcium-karbonátot,vagy alkálifém-hidrogén-karbonátot, például nátrium-hidrogénkarbonátotvagy kálium- hidrogén-karbonátot tartalmaz. Az aktív fázis legalábbegy olyan hatóanyagot tartalmaz, amely savas közegben ionos formábanvan jelen vagy savas pH-n elbomlik. A találmány tárgya továbbátabletta, amely legalább részben a fenti gyógyszerkészítményttartalmazza, valamint eljárás a tabletta előállítására. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9910285A FR2797185B1 (fr) | 1999-08-06 | 1999-08-06 | Composition pharmaceutique flottante comprenant une phase active et une phase non active |
PCT/FR2000/002223 WO2001010417A1 (fr) | 1999-08-06 | 2000-08-02 | Composition pharmaceutique flottante comprenant une phase active et une phase non active |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0202764A2 true HUP0202764A2 (hu) | 2003-01-28 |
HUP0202764A3 HUP0202764A3 (en) | 2004-05-28 |
Family
ID=9548990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0202764A HUP0202764A3 (en) | 1999-08-06 | 2000-08-02 | Floating pharmaceutical composition comprising an active phase and a non-active phase |
Country Status (12)
Country | Link |
---|---|
US (1) | US7682629B1 (hu) |
EP (1) | EP1206247B1 (hu) |
AT (1) | ATE450254T1 (hu) |
AU (1) | AU779036B2 (hu) |
BR (1) | BR0013106A (hu) |
CA (1) | CA2378988C (hu) |
DE (1) | DE60043442D1 (hu) |
FR (1) | FR2797185B1 (hu) |
HU (1) | HUP0202764A3 (hu) |
IL (2) | IL148003A0 (hu) |
NO (1) | NO20020572L (hu) |
WO (1) | WO2001010417A1 (hu) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1411901B1 (en) | 2001-07-04 | 2010-08-18 | Sun Pharma Advanced Research Company Ltd | Gastric retention controlled drug delivery system |
BR0309691A (pt) * | 2002-12-20 | 2005-08-02 | Hoffmann La Roche | Formulação de ibandronato em alta dose |
TW200533391A (en) | 2004-03-25 | 2005-10-16 | Sun Pharmaceutical Ind Ltd | Gastric retention drug delivery system |
US20080274180A1 (en) * | 2005-08-30 | 2008-11-06 | Nicholas Piramal India Limited | Extended Release Pharmaceutical Composition of Metformin and a Process for Producing It |
WO2010020098A1 (zh) | 2008-08-18 | 2010-02-25 | 北京天衡药物研究院 | 胃滞留药物释出系统及其制备方法和用途 |
JP5545952B2 (ja) * | 2007-08-31 | 2014-07-09 | 第一三共株式会社 | 徐放性製剤及びその製造方法 |
FR2938431B1 (fr) | 2008-11-14 | 2013-12-20 | Debregeas Et Associes Pharma | Nouvelle composition a base d'acide gamma-hydroxybutyrique |
FR2949062B1 (fr) | 2009-08-12 | 2011-09-02 | Debregeas Et Associes Pharma | Nouvelles formulations pharmaceutiques contre le mesusage des medicaments |
FR2949061B1 (fr) * | 2009-08-12 | 2013-04-19 | Debregeas Et Associes Pharma | Microgranules flottants |
FR2967352B1 (fr) * | 2010-11-12 | 2012-12-28 | Unither Dev | Comprime effervescent pour l'administration par voie orale de principes actifs |
WO2015089420A1 (en) | 2013-12-13 | 2015-06-18 | Biogen Idec Ma Inc. | Controlled release dosage form for once daily administration of dimethyl fumarate |
WO2019126218A1 (en) * | 2017-12-18 | 2019-06-27 | Tris Pharma, Inc. | Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release |
US11337920B2 (en) | 2017-12-18 | 2022-05-24 | Tris Pharma, Inc. | Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release |
IL275312B1 (en) | 2017-12-18 | 2024-05-01 | Tris Pharma Inc | GHB pharmacy preparations containing a system that creates a floating integrated penetrating polymer network |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4167558A (en) * | 1976-02-13 | 1979-09-11 | Hoffmann-La Roche Inc. | Novel sustained release tablet formulations |
JPS62195323A (ja) | 1986-02-24 | 1987-08-28 | Eisai Co Ltd | 胃内滞留型粒子 |
DE3803482A1 (de) * | 1988-02-05 | 1989-08-17 | Lohmann Therapie Syst Lts | Schwimmfaehiges orales therapeutisches system |
DE4403943A1 (de) * | 1994-02-08 | 1995-08-10 | Hexal Pharma Gmbh | Orale Azrneimittelzubereitung mit Diclofenac-Natrium |
DE4406424A1 (de) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
US5783212A (en) * | 1996-02-02 | 1998-07-21 | Temple University--of the Commonwealth System of Higher Education | Controlled release drug delivery system |
IT1282650B1 (it) * | 1996-02-19 | 1998-03-31 | Jagotec Ag | Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici |
FR2766708B1 (fr) * | 1997-07-30 | 2000-05-05 | Galenix Dev | Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention |
US6197328B1 (en) * | 1999-08-20 | 2001-03-06 | Dott Research Laboratory | Nasally administrable compositions |
-
1999
- 1999-08-06 FR FR9910285A patent/FR2797185B1/fr not_active Expired - Fee Related
-
2000
- 2000-08-02 IL IL14800300A patent/IL148003A0/xx active IP Right Grant
- 2000-08-02 CA CA2378988A patent/CA2378988C/fr not_active Expired - Fee Related
- 2000-08-02 AU AU68487/00A patent/AU779036B2/en not_active Ceased
- 2000-08-02 WO PCT/FR2000/002223 patent/WO2001010417A1/fr active IP Right Grant
- 2000-08-02 BR BR0013106-7A patent/BR0013106A/pt not_active Application Discontinuation
- 2000-08-02 HU HU0202764A patent/HUP0202764A3/hu unknown
- 2000-08-02 DE DE60043442T patent/DE60043442D1/de not_active Expired - Lifetime
- 2000-08-02 AT AT00956599T patent/ATE450254T1/de not_active IP Right Cessation
- 2000-08-02 US US10/048,459 patent/US7682629B1/en not_active Expired - Fee Related
- 2000-08-02 EP EP00956599A patent/EP1206247B1/fr not_active Expired - Lifetime
-
2002
- 2002-02-05 IL IL148003A patent/IL148003A/en not_active IP Right Cessation
- 2002-02-05 NO NO20020572A patent/NO20020572L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20020572L (no) | 2002-04-03 |
CA2378988A1 (fr) | 2001-02-15 |
HUP0202764A3 (en) | 2004-05-28 |
FR2797185B1 (fr) | 2001-10-26 |
US7682629B1 (en) | 2010-03-23 |
DE60043442D1 (de) | 2010-01-14 |
BR0013106A (pt) | 2002-07-23 |
CA2378988C (fr) | 2012-04-17 |
FR2797185A1 (fr) | 2001-02-09 |
WO2001010417A1 (fr) | 2001-02-15 |
AU779036B2 (en) | 2005-01-06 |
NO20020572D0 (no) | 2002-02-05 |
ATE450254T1 (de) | 2009-12-15 |
IL148003A0 (en) | 2002-09-12 |
EP1206247B1 (fr) | 2009-12-02 |
AU6848700A (en) | 2001-03-05 |
IL148003A (en) | 2007-06-03 |
EP1206247A1 (fr) | 2002-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0202764A2 (hu) | Aktív és inaktív fázist tartalmazó, úszó gyógyszerkészítmény | |
CA2121435A1 (en) | Aqueous pharmaceutical suspension and process for preparation thereof | |
HUP9904115A2 (hu) | Eljárás élelmiszer-adalékként felhasználható gyöngyök előállítására | |
AR006012A1 (es) | Tabletas que contienen antibioticos de beta-lactamas y un metodo para obtenerlas | |
HUP0201626A2 (hu) | Beültethető gélkészítmények és eljárás gyártásukra | |
HUP0300541A2 (hu) | Fluvasztatint tartalmazó nyújtott hatású gyógyászati készítmények | |
CA2461708A1 (en) | Delivery system for biological component | |
HUP0104472A2 (hu) | Nyújtott leadású mátrix jól oldódó hatóanyagokhoz | |
HUP0203257A2 (hu) | Atorvastatin kalcium polimorf módosulatai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
GB2399851A (en) | Acid soluble, high fluid loss pill for lost circulation | |
KR840006366A (ko) | 고정효소 제제의 제조방법 | |
JP2005508981A5 (hu) | ||
AU2895784A (en) | Particulate n-acetyl-p-aminophenol composition | |
PE20001058A1 (es) | Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial | |
HRP20020198B1 (en) | Moxifloxacin formulation containing common salt | |
CA2294812A1 (fr) | Composition pharmaceutique solide contenant des derives de benzofuranne | |
HUP9903209A2 (hu) | Forrasztóanyag-mentes alumíniumforrasztás | |
ES2188011T3 (es) | Agente de contraste para la reproduccion en imagenes de infartos y necrosis. | |
PL346764A1 (en) | New oral formulation for 5-ht4 | |
HUP0200226A2 (hu) | Eljárás mikroorganizmusok lekűzdéséhez cukortartalmú, vizes eljárásközegben | |
HUP9601321A3 (en) | Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them their use as pharmaceutical compositions or diagnostica, and the use of the said compds. | |
HUP0300189A2 (hu) | Lipid hordozó készítmény | |
NZ500288A (en) | Gastric-retained pharmaceutical composition comprising benzamide as the active principle and a carbon dioxide generating system | |
NO20002962D0 (no) | FremgangsmÕte for fremstilling av fludarabinfosfatlium-, - natrium-, -kalium-, -kalsium- og -magnesiumsalter, fremgangsmÕte for rensing av fludarabinfosfat, og fludarabinfosfat som er minst 99,5% rent | |
BG103739A (en) | Aqueous pharmaceutical composition containing hard soluble active substance in water |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |